Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Joins Alliance Developing High-throughput Phenotype-Genotype Platform

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genedata today announced its participation in an industry-led consortium to develop a high-throughput phenotype-genotype platform for the identification of complex genetic effects.

As part of its participation, the Genedata Selector software system will be used for the analysis and management of the biologically relevant production phenotype strains and processes.

The project, called the Integrated Phenotype-Genotype project, is integrating high-throughput phenotyping and genotyping platforms with the resulting platform based on Genedata Selector, which supports industrial biotechnology strain optimization and next-generation sequencing technologies.

"The platform uses parallelized, multiplexed phenotype assays to support the systematic processing, storage, and mining of large volumes of data," Genedata said, adding that the main applications for the platform are in industrial biotech strain and process development.

IPG is funded by the German Federal Ministry of Education and Research. Members of IPG, which include Evonik Industries, GATC, and the Bielefeld University Center of Biotechnology, are contributing intellectual property and technologies to the development of the platform.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.